Molecular mechanism of down-regulation of MSH2 expression by Hsp90 inhibitors to enhance cytotoxicity of tamoxifen in human squamous cell lung carcinoma
碩士 === 國立嘉義大學 === 生化科技學系研究所 === 103 === The anti-estrogen tamoxifen has been used worldwide as an adjuvant hormone therapeutic agent in the treatment of breast cancer. However, clinical studies has show that tamoxifen-induced cytotoxicity also occurred in non-small cell lung cancer (NSCLC) cells. Ho...
Main Authors: | Jhan-Jhang, Syu, 許展彰 |
---|---|
Other Authors: | Yun-Wei, Lin |
Format: | Others |
Language: | en_US |
Online Access: | http://ndltd.ncl.edu.tw/handle/32173685965868881468 |
Similar Items
-
Investigation the role of MSH2 expression in Hsp90 inhibitor enhancing pemetrexed-induced cytotoxicity in human lung cancer cells
by: Yi-Jun Jian, et al. -
Tamoxifen enhances the Hsp90 molecular chaperone ATPase activity.
by: Rongmin Zhao, et al.
Published: (2010-04-01) -
The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
by: Roberto Gomez-Casal, et al.
Published: (2015-05-01) -
Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma
by: Ángela Marrugal, et al.
Published: (2021-03-01) -
Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
by: Mark R. Woodford, et al.
Published: (2016-02-01)